section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in both dextrose 5% and sodium chloride 0.9%.

d Tested in sterile water for injection.

e Lyophilized formulation tested.

f Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

g Run at 21 mL/hr.

h Given over 30 minutes by syringe pump.

i Run at 94 mL/hr.

j Test performed using the formulation WITHOUT edetate disodium.

k Tested in Ringer’s injection, lactated.

l Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

m Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

n Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

o Test performed using the formulation WITH edetate disodium.

p Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

q Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.